In a biotech company, the CEO is the strategic anchor – balancing scientific understanding with business acumen.

They set the vision, drive fundraising, manage stakeholders, and ultimately decide when and how to move things forward.

They’re responsible for aligning internal teams with investor expectations, making tough calls about partnerships, and balancing long-term value creation with short-term milestones.

In early-stage biotechs, CEOs are often deeply involved in everything – from hiring and IP strategy to trial timelines and financing rounds. And as the company matures, the role can become more about direction-setting, team-building, and managing external relationships.

But if timelines slip due to enrolment issues, it’s the CEO who ultimately answers to investors and the board.

So by embedding recruitment thinking into the structure of their trials, biotech CEOs can ensure this function receives the type of support needed to bring new life-changing treatments to market.